Sign up to save your podcasts
Or
Share Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko
We love to hear from our listeners. Send us a message.
Elixirgen Therapeutics' Aki Ko joins Erin Harris to detail the company's Bobcat mRNA therapeutic and how it differs from traditional exon-skipping drugs and AAV-microdystrophin in treating DMD. Regarding delivery, Ko explains the advantage of the mRNA approach over the AAV approach.
Subscribe to the podcast!
Apple | Spotify | YouTube
View all episodes
By Erin Harris
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
Elixirgen Therapeutics' Aki Ko joins Erin Harris to detail the company's Bobcat mRNA therapeutic and how it differs from traditional exon-skipping drugs and AAV-microdystrophin in treating DMD. Regarding delivery, Ko explains the advantage of the mRNA approach over the AAV approach.
Subscribe to the podcast!
Apple | Spotify | YouTube
More shows like Cell & Gene: The Podcast
View all
Nature Podcast
765 Listeners
Science Magazine Podcast
807 Listeners
Economist Podcasts
4,256 Listeners
Freakonomics Radio
32,030 Listeners
The Long Run with Luke Timmerman
124 Listeners
Immune
271 Listeners
The Readout Loud
318 Listeners
FT News Briefing
697 Listeners
Business Of Biotech
88 Listeners
BioCentury This Week
31 Listeners
Raising Health
147 Listeners
Biotech Hangout
11 Listeners
ASGCT Podcast Network
15 Listeners
Elon, Inc.
149 Listeners
Ground Truths
48 Listeners